Alexander Yeh, MD
Radiation Oncology · Indianapolis, INNPI 1275533010
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,033 of the $3,165 with a category attached, or 64.2%. 27 manufacturers reported payments, led by Medtronic at 55.6% of the total. Reporting peaked in 2024 at $1,776 and has fallen 99.0% since, to $18 in 2025.
Across 63 payments — averaging $50.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Varian Medical Systems, Inc.$235
- Novocure Inc.$149
- Puma Biotechnology, Inc.$125
- Lilly USA, LLC$124
- Eisai Inc.$98
- plus $675 from 21 others
What the payments were for
- Travel & lodging$1,13236%
- Food & beverage$2,03364%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 8 | $1,759 |
| Varian Medical Systems, Inc. | 2 | $235 |
| Novocure Inc. | 1 | $149 |
| Puma Biotechnology, Inc. | 1 | $125 |
| Lilly USA, LLC | 2 | $124 |
| Eisai Inc. | 3 | $98 |
| Tersera Therapeutics LLC | 6 | $81 |
| Novartis | 5 | $80 |
| AstraZeneca | 6 | $78 |
| Johnson & Johnson(2 entities) | 4 | $56 |
| Merck | 3 | $46 |
| Amgen | 3 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| Incyte Corporation | 2 | $30 |
| Bayer | 2 | $27 |
| Bristol Myers Squibb | 2 | $26 |
| Daiichi Sankyo Inc. | 2 | $24 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $19 |
| Tris Pharma Inc | 1 | $18 |
| Exelixis Inc. | 1 | $16 |
| EMD Serono, Inc. | 1 | $16 |
| Sanofi | 1 | $16 |
| Boehringer Ingelheim | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $12 |
| Rigel Pharmaceuticals, Inc. | 1 | $12 |
| Pfizer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KYPHON EXPRESS II KYPHOPAK TRAY$1,388
- OSTEOCOOL RF ABLATION SYSTEM$207
- Oncology$149
- Varian Ethos Treatment Planning$128
- Nerlynx$125
- Treatment Planning Systems$108
How this compares
$3,165 in reported general payments places this provider in the 85th percentile of 116 radiation oncology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 58 | $828 |
| Mometasone Furoate | 40 | $538 |
| Tamsulosin Hcl | 35 | $494 |
| Morphine Sulfate ErMorphine Sulfate | 11 | $303 |
| Methylprednisolone | 15 | $112 |
| Fluconazole | 12 | $106 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Indianapolis
- Michael EatonIndianapolis$11K
- Gordon WatsonIndianapolis$6K
- John CoxIndianapolis$5K
- Peter GarrettIndianapolis$5K
- Garrett JensenIndianapolis$4K
- Erin McCammackIndianapolis$2K
- Zachary OaksIndianapolis$2K
- David KimIndianapolis$2K
- Darrel RossIndianapolis$2K
- Craig SchneiderIndianapolis$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.